       Document 0165
 DOCN  M9610165
 TI    [Kaposi disease, limited to the skin, in ulcerated hemorrhagic
       rectocolitis]
 DT    9601
 AU    Bolla G; Disdier P; Swiader L; Andrac L; Vacheret H; Sahel J; Harle JR;
       Weiller PJ; Service de medecine interne, CHU La Timone, bd Jean-Moulin,;
       Marseille, France.
 SO    Rev Med Interne. 1995;16(7):524-6. Unique Identifier : AIDSLINE
       MED/96008890
 AB    We report the first case of limited cutaneous Kaposi's sarcoma during
       ulcerative colitis, in a HIV-negative 68 year-old man without any risk
       factors for this tumor. In our case, the steroid-therapy necessitated by
       the colitis is the most important aetiological factor of the sarcoma and
       its withdrawal leads to a complete remission of the tumor. The link
       between steroid-therapy and Kaposi's sarcoma is well known. A link
       between ulcerative colitis and Kaposi's sarcoma can be discussed but not
       proven. The possible occurrence of this cutaneous tumor during
       ulcerative colitis is of interest.
 DE    Aged  Case Report  Colitis, Ulcerative/*COMPLICATIONS/DRUG
       THERAPY/PHYSIOPATHOLOGY  English Abstract  Human  Male
       Prednisone/THERAPEUTIC USE  Risk Factors  Sarcoma, Kaposi's/*ETIOLOGY
       Skin Neoplasms/*ETIOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

